🇺🇸 FDA
Company

SUTRO

SUTRO BIOPHARMA, INC.

STRO biotech USA

Quick answer

SUTRO is a biotech company (STRO) headquartered in SOUTH SAN FRANCISCO, CA, USA with 7 tracked pipeline programs.

Pipeline (7)

project

Luveltamab tazevibulin

Ovarian Cancer

Phase 3 · small_molecule · terminated

1 trials project

Luveltamab tazevibulin

Lung Cancer

Phase 2 · small_molecule · terminated

1 trials project

Luveltamab tazevibulin

Acute Myeloid Leukemia (AML)

Phase 2 · small_molecule · terminated

1 trials project

STRO-002

Neoplasm Malignant

Phase 2 · mab · completed

1 trials project

STRO-001

B-cell Lymphoma

Phase 1 · small_molecule · completed

1 trials project

STRO-002

Ovarian Cancer

Phase 1 · small_molecule · completed

2 trials project

STRO-004

Head and Neck Squamous Cell Carcinoma HNSCC

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12427201

Anti-folate receptor antibody conjugates, compositions comprising anti-folate re

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12398197

Antibodies with engineered CH2 domains, compositions thereof and methods of usin

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12351850

Methods of producing full-length antibodies using E. coli

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12269801

Modified amino acids

Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12252552

Modified Fc proteins comprising site-specific non-natural amino acid residues, c

Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12226490

Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjug

Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12144869

Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjug

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12071477

Anti-folate receptor alpha antibody conjugated with hemiasterlins

Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)